Optima Medical Innovations (Optima Medical Innovations) ROCE % : -11.36% (As of Sep. 2021)

View and export this data going back to 2018. Start your Free Trial

What is Optima Medical Innovations ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Optima Medical Innovations's annualized ROCE % for the quarter that ended in Sep. 2021 was -11.36%.

Optima Medical Innovations ROCE % Historical Data

The historical data trend for Optima Medical Innovations's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optima Medical Innovations ROCE % Chart

Optima Medical Innovations Annual Data

Trend

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

ROCE %

Get a 7-Day Free Trial

-49.83

-180.39

-465.06

-58.35

Optima Medical Innovations Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
ROCE %	Get a 7-Day Free Trial															-23.59	27.06	7.97	6.80	-11.36

Optima Medical Innovations ROCE % Calculation

Optima Medical Innovations's annualized ROCE % for the fiscal year that ended in Dec. 2020 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2020 )		(A: Dec. 2019 )		(A: Dec. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2020 )		(A: Dec. 2019 )		(A: Dec. 2020 )
	=	-3.44	/	( ( (10.432 - 2.796)	+	(7.224 - 3.07) )	/ 2 )
	=	-3.44	/	( (7.636	+	4.154)	/ 2 )
	=	-3.44	/	5.895
	=	-58.35 %

Optima Medical Innovations's ROCE % of for the quarter that ended in Sep. 2021 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2021 )		(Q: Jun. 2021 )		(Q: Sep. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2021 )		(Q: Jun. 2021 )		(Q: Sep. 2021 )
	=	-0.468	/	( ( (7.015 - 2.715)	+	(6.511 - 2.575) )	/ 2 )
	=	-0.468	/	( ( 4.3	+	3.936 )	/ 2 )
	=	-0.468	/	4.118
	=	-11.36 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2021) EBIT data.

Optima Medical Innovations (OTCPK:TOKIF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Optima Medical Innovations ROCE % Related Terms

Thank you for viewing the detailed overview of Optima Medical Innovations's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Optima Medical Innovations (Optima Medical Innovations) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Optima Medical Innovations Corp (OTCPK:TOKIF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5460 Yonge Street, Unit 209, Toronto, ON, CAN, M2N 6K7

Website

https://www.tokicorp.com

Optima Medical Innovations Corp delivers pathways to innovative, science-based health and wellness solutions. It focuses on multi-disciplinary pain management. The group is also engaged in the development of solutions, products and treatments for pain relief, wellness and Cancer therapy.